Welcome to the latest episode of the Full-Court Finance podcast from Zacks Investment Research where Associate Stock Strategist Ben Rains dives into connected stationary bike firm Peloton Interactive Inc. after it filed confidentially for an initial public offering. The announcement comes on the heels of Beyond Meat’s (BYND - Free Report) early success and during a busy time for much-hyped giants like Uber (UBER - Free Report) .
We recently dove into Beyond Meat on the podcast, which saw its stock price skyrocket once against Friday after the company’s first quarterly earnings report as a public company impressed Wall Street. Not to be outdone, e-commerce retailer Revolve Group RVLV stock soared on its first day on the public markets on June 7. Meanwhile, Pinterest (PINS - Free Report) , Uber, and Lyft (LYFT - Free Report) have been up and down early on.
In terms of Peloton, the firm sells connected stationary bikes for as much as $2,694. More recently, the New York-based company rolled out treadmills as it looks to expand its business in the lead up to a possible IPO. On top of the physical bikes and treadmills, Peloton’s monthly memberships that offer access to video-based workout classes seem to be the real selling point and differentiator.
Peloton was last valued at $4.15 billion and competes with fitness firms such as SoulCycle and Flywheel Sports. The firm is certainly worth keeping an eye on ahead of a possible IPO as it combines two popular and successful business models.
The firm sells branded high-end physical products that have become popular and stand out in crowded markets much like Lululemon (LULU - Free Report) , Canada Goose (GOOS - Free Report) , and Yeti (YETI - Free Report) . At the same time, Peloton’s monthly subscription business has been called the Netflix (NFLX - Free Report) for fitness and will likely help drive the company forward in a world where stationary bikes and treadmills can be purchased on Amazon (AMZN - Free Report) and Dicks Sporting Goods (DKS - Free Report) for far less.
As a reminder, if you feel that we missed something, or if you have any topic suggestions, shoot us an email at email@example.com. Make sure to check out all of our other audio content at zacks.com/podcasts, and remember to subscribe and leave us a rating wherever you listen to your podcasts.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>